메뉴 건너뛰기




Volumn 20, Issue 5, 2011, Pages 471-475

Newer renin-angiotensin-aldosterone system blocker combinations: Is there an advantage?

Author keywords

cardiovascular; combination therapy; hypertension; kidney

Indexed keywords

ALDOSTERONE ANTAGONIST; ALISKIREN; AMLODIPINE; AMLODIPINE BESYLATE; AMLODIPINE PLUS BENAZEPRIL; ANGIOTENSIN RECEPTOR ANTAGONIST; AZILSARTAN; BENAZEPRIL; CALCIUM CHANNEL BLOCKING AGENT; CHLORTALIDONE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; HYDROCHLOROTHIAZIDE; IRBESARTAN; NONDIHYDROPYRIDINE; OLMESARTAN; OLMESARTAN MEDOXIMIL; RENIN INHIBITOR; TELMISARTAN; UNCLASSIFIED DRUG; VALSARTAN;

EID: 80051802107     PISSN: 10624821     EISSN: 14736543     Source Type: Journal    
DOI: 10.1097/MNH.0b013e3283495819     Document Type: Review
Times cited : (3)

References (39)
  • 1
    • 79952444246 scopus 로고    scopus 로고
    • Forecasting the future of cardiovascular disease in the United States: A policy statement from the American Heart Association
    • Heidenreich PA, Trogdon JG, Khavjou OA, et al. Forecasting the future of cardiovascular disease in the United States: a policy statement from the American Heart Association. Circulation 2011;123:933-944.
    • (2011) Circulation , vol.123 , pp. 933-944
    • Heidenreich, P.A.1    Trogdon, J.G.2    Khavjou, O.A.3
  • 2
    • 23244440534 scopus 로고    scopus 로고
    • Blood pressure in adulthood and life expectancy with cardiovascular disease in men and women: Life course analysis
    • DOI 10.1161/01.HYP.0000173433.67426.9b
    • Franco OH, Peeters A, Bonneux L, De LC. Blood pressure in adulthood and life expectancy with cardiovascular disease in men and women: life course analysis. Hypertension 2005;46:280-286. (Pubitemid 41099158)
    • (2005) Hypertension , vol.46 , Issue.2 , pp. 280-286
    • Franco, O.H.1    Peeters, A.2    Bonneux, L.3    De Laet, C.4
  • 3
    • 79952277735 scopus 로고    scopus 로고
    • Recent trends in the prevalence of high blood pressure and its treatment and control, 1999-2008
    • Yoon SS, Ostchega Y, Louis T. Recent trends in the prevalence of high blood pressure and its treatment and control, 1999-2008. NCHS. Data Brief. 2010, 1-8.
    • (2010) NCHS. Data Brief , pp. 1-8
    • Yoon, S.S.1    Ostchega, Y.2    Louis, T.3
  • 4
    • 77955926118 scopus 로고    scopus 로고
    • Systemic hemodynamics and regional blood flow regulation
    • IzzoJL, Black HR, editors, 4th ed. Council for High Blood Pressure Research American Heart Association. Philadelphia, PA: Lippincott, Williams & Wilkins
    • Izzo JL, Black HR, Sica DA. Systemic hemodynamics and regional blood flow regulation. In IzzoJL, Black HR, editors. Hypertension primer: the essentials of high blood pressure: basic science and clinical management. 4th ed. Council for High Blood Pressure Research (American Heart Association). Philadelphia, PA: Lippincott, Williams & Wilkins; 2008. pp. 36-44.
    • (2008) Hypertension Primer: The Essentials of High Blood Pressure: Basic Science and Clinical Management , pp. 36-44
    • Izzo, J.L.1    Black, H.R.2    Sica, D.A.3
  • 6
    • 73649089010 scopus 로고    scopus 로고
    • Renal and cardio-protective effects of direct renin inhibition: A systematic literature review
    • Lambers Heerspink HJ, Perkovic V, de Zeeuw D. Renal and cardio-protective effects of direct renin inhibition: a systematic literature review. J Hypertens 2009;27:2321-2331.
    • (2009) J Hypertens , vol.27 , pp. 2321-2331
    • Lambers Heerspink, H.J.1    Perkovic, V.2    De Zeeuw, D.3
  • 7
    • 77951085291 scopus 로고    scopus 로고
    • Evidence for the efficacy of ARBs across the cardiovascular continuum
    • Gupta M, Honos GN, Velazquez EJ, et al. Evidence for the efficacy of ARBs across the cardiovascular continuum. Curr Med Res Opin 2010;26:1203-1218.
    • (2010) Curr Med Res Opin , vol.26 , pp. 1203-1218
    • Gupta, M.1    Honos, G.N.2    Velazquez, E.J.3
  • 8
    • 76149089578 scopus 로고    scopus 로고
    • Role of angiotensin-converting enzyme inhibitors in vascular modulation: Beyond the hypertensive effects
    • Katragadda S, Arora RR. Role of angiotensin-converting enzyme inhibitors in vascular modulation: beyond the hypertensive effects. Am J Ther 2010;17:e11-e23.
    • (2010) Am J Ther , vol.17
    • Katragadda, S.1    Arora, R.R.2
  • 9
    • 77749332022 scopus 로고    scopus 로고
    • Combination therapy in hypertension
    • Gradman AH, Basile JN, Carter BL, Bakris GL. Combination therapy in hypertension. J Am Soc Hypertens 2010;4:42-50. This article summarizes the most current recommendations and rationale for combination therapy in the management of hypertension.
    • (2010) J Am Soc Hypertens , vol.4 , pp. 42-50
    • Gradman, A.H.1    Basile, J.N.2    Carter, B.L.3    Bakris, G.L.4
  • 11
    • 21744458786 scopus 로고    scopus 로고
    • Managing hypertension: A question of STRATHE
    • DOI 10.1038/sj.jhh.1001886
    • Zannad F. Managing hypertension: a question of STRATHE. J Hum Hypertens 2005;19(Suppl 1):S3-S7. (Pubitemid 40946028)
    • (2005) Journal of Human Hypertension , vol.19 , Issue.SUPPL. 1
    • Zannad, F.1
  • 12
    • 0037490085 scopus 로고    scopus 로고
    • Value of low dose combination treatment with blood pressure lowering drugs: Analysis of 354 randomised trials
    • Law MR, Wald NJ, Morris JK, Jordan RE. Value of low dose combination treatment with blood pressure lowering drugs: analysis of 354 randomised trials. Br Med J 2003;326:1427.
    • (2003) Br Med J , vol.326 , pp. 1427
    • Law, M.R.1    Wald, N.J.2    Morris, J.K.3    Jordan, R.E.4
  • 13
    • 61649091385 scopus 로고    scopus 로고
    • Combination therapy versus monotherapy in reducing blood pressure: Meta-analysis on 11, 000 participants from 42 trials
    • Wald DS, Law M, Morris JK, et al. Combination therapy versus monotherapy in reducing blood pressure: meta-analysis on 11, 000 participants from 42 trials. Am J Med 2009;122:290-300.
    • (2009) Am J Med , vol.122 , pp. 290-300
    • Wald, D.S.1    Law, M.2    Morris, J.K.3
  • 14
    • 64849106873 scopus 로고    scopus 로고
    • A simplified approach to the treatment of uncomplicated hypertension: A cluster randomized, controlled trial
    • Feldman RD, Zou GY, Vandervoort MK, et al. A simplified approach to the treatment of uncomplicated hypertension: a cluster randomized, controlled trial. Hypertension 2009;53:646-653.
    • (2009) Hypertension , vol.53 , pp. 646-653
    • Feldman, R.D.1    Zou, G.Y.2    Vandervoort, M.K.3
  • 15
    • 34250179723 scopus 로고    scopus 로고
    • Fixed-Dose Combinations Improve Medication Compliance: A Meta-Analysis
    • DOI 10.1016/j.amjmed.2006.08.033, PII S000293430601151X
    • Bangalore S, Kamalakkannan G, Parkar S, Messerli FH. Fixed-dose combinations improve medication compliance: a meta-analysis. Am J Med 2007;120:713-719. (Pubitemid 47176510)
    • (2007) American Journal of Medicine , vol.120 , Issue.8 , pp. 713-719
    • Bangalore, S.1    Kamalakkannan, G.2    Parkar, S.3    Messerli, F.H.4
  • 16
    • 80051788734 scopus 로고
    • Perindopril/hydrochlorothiazide combination in hypertensive patients unresponsive to hydrochlorothiazide alone: A double-blind, multicenter study
    • Weiss RJ, Sandall PG, Chrysant SG. Perindopril/hydrochlorothiazide combination in hypertensive patients unresponsive to hydrochlorothiazide alone: a double-blind, multicenter study. Am J Ther 1994;1:125-132.
    • (1994) Am J Ther , vol.1 , pp. 125-132
    • Weiss, R.J.1    Sandall, P.G.2    Chrysant, S.G.3
  • 17
    • 0028296024 scopus 로고
    • Antihypertensive effectiveness of low-dose lisinopril-hydrochlorothiazide combination: A large multicenter study
    • DOI 10.1001/archinte.154.7.737
    • Chrysant SG. Antihypertensive effectiveness of low-dose lisinopril-hydrochlorothiazide combination. A large multicenter study. Lisinopril-Hydrochlorothiazide Group. Arch Intern Med 1994;154:737-743. (Pubitemid 24115660)
    • (1994) Archives of Internal Medicine , vol.154 , Issue.7 , pp. 737-743
    • Chrysant, S.G.1
  • 18
    • 33845366982 scopus 로고    scopus 로고
    • Renin inhibition with aliskiren provides additive antihypertensive efficacy when used in combination with hydrochlorothiazide
    • DOI 10.1097/HJH.0b013e3280103a6b, PII 0000487220070100000030
    • Villamil A, Chrysant SG, Calhoun D, et al. Renin inhibition with aliskiren provides additive antihypertensive efficacy when used in combination with hydrochlorothiazide. J Hypertens 2007;25:217-226. (Pubitemid 44885684)
    • (2007) Journal of Hypertension , vol.25 , Issue.1 , pp. 217-226
    • Villamil, A.1    Chrysant, S.G.2    Calhoun, D.3    Schober, B.4    Hsu, H.5    Matrisciano-Dimichino, L.6    Zhang, J.7
  • 19
    • 12744263227 scopus 로고    scopus 로고
    • Fixed-dose combinations in the management of hypertension: Defining the place of angiotensin receptor antagonists and hydrochlorothiazide
    • Kjeldsen SE, Os I, Hoieggen A, et al. Fixed-dose combinations in the management of hypertension: defining the place of angiotensin receptor antagonists and hydrochlorothiazide. Am J Cardiovasc Drugs 2005;5:17-22.
    • (2005) Am J Cardiovasc Drugs , vol.5 , pp. 17-22
    • Kjeldsen, S.E.1    Os, I.2    Hoieggen, A.3
  • 20
    • 79251482491 scopus 로고    scopus 로고
    • Comparison of the antihypertensive efficacy of irbesartan/HCTZ and valsartan/HCTZ combination therapy: Impact of age and gender
    • Asmar R, Oparil S. Comparison of the antihypertensive efficacy of irbesartan/HCTZ and valsartan/HCTZ combination therapy: impact of age and gender. Clin Exp Hypertens 2010;32:499-503.
    • (2010) Clin Exp Hypertens , vol.32 , pp. 499-503
    • Asmar, R.1    Oparil, S.2
  • 21
    • 77958455774 scopus 로고    scopus 로고
    • Evaluating 24-h antihypertensive efficacy by the smoothness index: A meta-analysis of an ambulatory blood pressure monitoring database
    • Parati G, Schumacher H, Bilo G, Mancia G. Evaluating 24-h antihypertensive efficacy by the smoothness index: a meta-analysis of an ambulatory blood pressure monitoring database. J Hypertens 2010;28:2177-2183. This meta-analysis gives further insight into the importance of continuous BP lowering with the combination medication approach.
    • (2010) J Hypertens , vol.28 , pp. 2177-2183
    • Parati, G.1    Schumacher, H.2    Bilo, G.3    Mancia, G.4
  • 22
    • 77749245884 scopus 로고    scopus 로고
    • Limitations of the usual blood-pressure hypothesis and importance of variability, instability, and episodic hypertension
    • Rothwell PM. Limitations of the usual blood-pressure hypothesis and importance of variability, instability, and episodic hypertension. Lancet 2010;375:938-948.
    • (2010) Lancet , vol.375 , pp. 938-948
    • Rothwell, P.M.1
  • 23
    • 77749251836 scopus 로고    scopus 로고
    • Prognostic significance of visit-tovisit variability, maximum systolic blood pressure, and episodic hypertension
    • Rothwell PM, Howard SC, Dolan E, et al. Prognostic significance of visit-tovisit variability, maximum systolic blood pressure, and episodic hypertension. Lancet 2010;375:895-905.
    • (2010) Lancet , vol.375 , pp. 895-905
    • Rothwell, P.M.1    Howard, S.C.2    Dolan, E.3
  • 24
    • 34249289026 scopus 로고    scopus 로고
    • Long-term prognostic value of blood pressure variability in the general population: Results of the Pressioni Arteriose Monitorate e Lassociazioni Study
    • DOI 10.1161/HYPERTENSIONAHA.107.088708
    • Mancia G, Bombelli M, Facchetti R, et al. Long-term prognostic value of blood pressure variability in the general population: results of the Pressioni Arteriose Monitorate e Loro Associazioni Study. Hypertension 2007;49:1265-1270. (Pubitemid 46809367)
    • (2007) Hypertension , vol.49 , Issue.6 , pp. 1265-1270
    • Mancia, G.1    Bombelli, M.2    Facchetti, R.3    Madotto, F.4    Corrao, G.5    Trevano, F.Q.6    Grassi, G.7    Sega, R.8
  • 25
    • 79953239152 scopus 로고    scopus 로고
    • Effects of the angiotensin receptor blocker azilsartan medoxomil versus olmesartan and valsartan on ambulatory and clinic blood pressure in patients with stages 1 and 2 hypertension
    • White WB, Weber MA, Sica D, et al. Effects of the angiotensin receptor blocker azilsartan medoxomil versus olmesartan and valsartan on ambulatory and clinic blood pressure in patients with stages 1 and 2 hypertension. Hypertension 2011;57:413-420.
    • (2011) Hypertension , vol.57 , pp. 413-420
    • White, W.B.1    Weber, M.A.2    Sica, D.3
  • 26
    • 79251590265 scopus 로고    scopus 로고
    • The comparative effects of azilsartan medoxomil and olmesartan on ambulatory and clinic blood pressure
    • Bakris GL, Sica D, Weber M, et al. The comparative effects of azilsartan medoxomil and olmesartan on ambulatory and clinic blood pressure. J Clin Hypertens (Greenwich) 2011;13:81-88.
    • (2011) J Clin Hypertens (Greenwich) , vol.13 , pp. 81-88
    • Bakris, G.L.1    Sica, D.2    Weber, M.3
  • 27
    • 33644981542 scopus 로고    scopus 로고
    • Comparative antihypertensive effects of hydrochlorothiazide and chlorthalidone on ambulatory and office blood pressure
    • DOI 10.1161/01.HYP.0000203309.07140.d3, PII 0000426820060300000016
    • Ernst ME, Carter BL, Goerdt CJ, et al. Comparative antihypertensive effects of hydrochlorothiazide and chlorthalidone on ambulatory and office blood pressure. Hypertension 2006;47:352-358. (Pubitemid 43740274)
    • (2006) Hypertension , vol.47 , Issue.3 , pp. 352-358
    • Ernst, M.E.1    Carter, B.L.2    Goerdt, C.J.3    Steffensmeier, J.J.G.4    Phillips, B.B.5    Zimmerman, M.B.6    Bergus, G.R.7
  • 28
    • 79953219740 scopus 로고    scopus 로고
    • Chlorthalidone reduces cardiovascular events compared with hydrochlorothiazide: A retrospective cohort analysis
    • Dorsch MP, Gillespie BW, Erickson SR, et al. Chlorthalidone reduces cardiovascular events compared with hydrochlorothiazide: a retrospective cohort analysis. Hypertension 2011;57:689-694. This study provides imortant additional evidence for the implementation of chlorthalidone instead of hydrochlorothiazide in hypertensive patients.
    • (2011) Hypertension , vol.57 , pp. 689-694
    • Dorsch, M.P.1    Gillespie, B.W.2    Erickson, S.R.3
  • 29
    • 57349138291 scopus 로고    scopus 로고
    • Benazepril plus amlodipine or hydrochlorothiazide for hypertension in high-risk patients
    • Jamerson K, Weber MA, Bakris GL, et al. Benazepril plus amlodipine or hydrochlorothiazide for hypertension in high-risk patients. N Engl J Med 2008;359:2417-2428.
    • (2008) N Engl J Med , vol.359 , pp. 2417-2428
    • Jamerson, K.1    Weber, M.A.2    Bakris, G.L.3
  • 30
    • 0141798855 scopus 로고    scopus 로고
    • Achieving goal blood pressure in patients with type 2 diabetes: Conventional versus fixed-dose combination approaches
    • Bakris GL, Weir MR. Achieving goal blood pressure in patients with type 2 diabetes: conventional versus fixed-dose combination approaches. J Clin Hypertens (Greenwich) 2003;5:202-209. (Pubitemid 37428137)
    • (2003) Journal of Clinical Hypertension , vol.5 , Issue.3 , pp. 202-209
    • Bakris, G.L.1    Weir, M.R.2
  • 31
    • 0031657169 scopus 로고    scopus 로고
    • Effects of an ACE inhibitor/calcium antagonist combination on proteinuria in diabetic nephropathy
    • DOI 10.1046/j.1523-1755.1998.00083.x
    • Bakris GL, Weir MR, DeQuattro V, McMahon FG. Effects of an ACE inhibitor/calcium antagonist combination on proteinuria in diabetic nephropathy. Kidney Int 1998;54:1283-1289. (Pubitemid 28449916)
    • (1998) Kidney International , vol.54 , Issue.4 , pp. 1283-1289
    • Bakris, G.L.1    Weir, M.R.2    Dequattro, V.3    Mcmahon, F.G.4
  • 33
    • 34447109035 scopus 로고    scopus 로고
    • Two multicenter, 8-week, randomized, double-blind, placebo-controlled, parallel-group studies evaluating the efficacy and tolerability of amlodipine and valsartan in combination and as monotherapy in adult patients with mild to moderate essential hypertension
    • DOI 10.1016/j.clinthera.2007.03.018, PII S0149291807001002
    • Philipp T, Smith TR, Glazer R, et al. Two multicenter, 8-week, randomized, double-blind, placebo-controlled, parallel-group studies evaluating the efficacy and tolerability of amlodipine and valsartan in combination and as monotherapy in adult patients with mild to moderate essential hypertension. Clin Ther 2007;29:563-580. (Pubitemid 47028551)
    • (2007) Clinical Therapeutics , vol.29 , Issue.4 , pp. 563-580
    • Philipp, T.1    Smith, T.R.2    Glazer, R.3    Wernsing, M.4    Yen, J.5    Jin, J.6    Schneider, H.7    Pospiech, R.8
  • 34
    • 43549100189 scopus 로고    scopus 로고
    • The combination of olmesartan medoxomil and amlodipine besylate in controlling high blood pressure: COACH, a randomized, double-blind, placebo-controlled, 8-week factorial efficacy and safety study
    • DOI 10.1016/j.clinthera.2008.04.002, PII S0149291808001410
    • Chrysant SG, Melino M, Karki S, et al. The combination of olmesartan medoxomil and amlodipine besylate in controlling high blood pressure: COACH, a randomized, double-blind, placebo-controlled, 8-week factorial efficacy and safety study. Clin Ther 2008;30:587-604. (Pubitemid 351680489)
    • (2008) Clinical Therapeutics , vol.30 , Issue.4 , pp. 587-604
    • Chrysant, S.G.1    Melino, M.2    Karki, S.3    Lee, J.4    Heyrman, R.5
  • 35
    • 78649340508 scopus 로고    scopus 로고
    • Telmisartan/amlodipine: Single-pill combination in hypertension
    • Moen MD. Telmisartan/amlodipine: single-pill combination in hypertension. Am J Cardiovasc Drugs 2010;10:401-412.
    • (2010) Am J Cardiovasc Drugs , vol.10 , pp. 401-412
    • Moen, M.D.1
  • 36
    • 78751646571 scopus 로고    scopus 로고
    • Aliskiren and the calcium channel blocker amlodipine combination as an initial treatment strategy for hypertension control (ACCELERATE): A randomised, parallel-group trial
    • Brown MJ, McInnes GT, Papst CC, et al. Aliskiren and the calcium channel blocker amlodipine combination as an initial treatment strategy for hypertension control (ACCELERATE): a randomised, parallel-group trial. Lancet 2011;377:312-320. This recent trial gives further support for combination therapy implementation as initial approach in hypertensive patients with improved blood pressure outcomes in this group at the end of the trial compared with sequential therapy group.
    • (2011) Lancet , vol.377 , pp. 312-320
    • Brown, M.J.1    McInnes, G.T.2    Papst, C.C.3
  • 37
    • 78650399272 scopus 로고    scopus 로고
    • Olmesartan medoxomil, amlodipine besylate and hydrochlorothiazide triple combination for hypertension
    • Ram CV. Olmesartan medoxomil, amlodipine besylate and hydrochlorothiazide triple combination for hypertension. Expert Rev Cardiovasc Ther 2011;9:9-19.
    • (2011) Expert Rev Cardiovasc Ther , vol.9 , pp. 9-19
    • Ram, C.V.1
  • 38
    • 71149106247 scopus 로고    scopus 로고
    • Amlodipine/valsartan/hydrochlorothiazide: Fixed-dose combination in hypertension
    • Deeks ED. Amlodipine/valsartan/hydrochlorothiazide: fixed-dose combination in hypertension. Am J Cardiovasc Drugs 2009;9:411-418.
    • (2009) Am J Cardiovasc Drugs , vol.9 , pp. 411-418
    • Deeks, E.D.1
  • 39
    • 65249182083 scopus 로고    scopus 로고
    • Aliskiren trial in type 2 diabetes using cardio-renal endpoints (ALTITUDE): Rationale and study design
    • Parving HH, Brenner BM, McMurray JJ, et al. Aliskiren Trial in Type 2 Diabetes Using Cardio-Renal Endpoints (ALTITUDE): rationale and study design. Nephrol Dial Transplant 2009;24:1663-1671.
    • (2009) Nephrol Dial Transplant , vol.24 , pp. 1663-1671
    • Parving, H.H.1    Brenner, B.M.2    McMurray, J.J.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.